ga naar hoofdinhoud
Informatie voor zorgverleners Behandelprotocollen Chronische neutrofiele leukemie (CNL) Richtlijnen en literatuur

Richtlijnen

Er is op dit moment geen richtlijn voor CNL.

Literatuur

  1. Arber DA et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200-28
  2. Khoury JD et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36(7):1703-19
  3. Palomo L et al. Molecular landscape and clonal architecture of adult myelodysplastic/ myeloproliferative neoplasms. Blood 2020; 136(16):1851-62
  4. Dao KT et al. Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia. J Clin Oncol 2020;38(10):1006-18
  5. Mughal TI et al. An International MDS/MPN working group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/ myeloproliferative neoplasms. Haematologica 2015; 100(9):1117-30
  6. Savona MR et al. An international consortium proposal of uniform response criteria for myelodysplastic/ myeloproliferative neoplasms (MDS/MPN) in adults. Blood 2015; 125(12):1857-65

 

Ga terug naar de CNL homepage of lees meer over CNL:

Ga terug naar de algemene homepage Behandelprotocollen.